Recent posts

New Facility Concept

Gener8 Celebrates 20 Years of Business and Continued Growth

By Gener8 / September 16, 2022

Gener8 Celebrates 20 Years of Business and Continued Growth Sunnyvale, California – September 16th, 2022 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), celebrates the company’s 20th anniversary this month. Since its founding in September 2002 Gener8 has developed into a full product lifecycle engineering and…

Read more

Gener8 Welcomes Mark Chatfield as Global Vice President of Operations

By Gener8 / February 11, 2022

Sunnyvale, California – February 9, 2022 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), welcomes Mark Chatfield as the new Global Vice President of Operations. Mark brings thirty years of experience with Thermo Fisher Scientific running operations in the fields of specialized x-rays, chromatography, and mass…

Read more

Gener8 Has Acquired RND, Expanding Into Life Sciences Software Development

By Gener8 / December 9, 2021

Sunnyvale, California – December 9, 2021 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), announced today that it has completed its acquisition of the RND Group (“RND”), a leading provider of software development focused on medical device and life science products, based in Indianapolis, Indiana. With…

Read more

Gener8 Reorganizes Carlsbad Facility for Expanded Manufacturing Capabilities

By Gener8 / June 30, 2021

SUNNYVALE, Calif., June 30, 2021, Gener8 LLC (“Gener8”), a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, is restructuring its 15,000 sq. ft. Carlsbad facility to provide microfluidics cartridge design,…

Read more

Gener8 Expands into New Boston Location

By Gener8 / June 17, 2021

SUNNYVALE, Calif., June 17, 2021 — Gener8 LLC (“Gener8”), a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, announced today that it has expanded its services…

Read more